-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_disposition-comments.pdf
July 17, 2013 - This has been corrected in the “Description of
Included Studies” for this comparison, in Table 10 (Drugs … and
Usability
It might be beneficial if the Authors reviewed the document for
consistency of the description … In the Results section, funding is reported in the narrative
description of the evidence for each comparison … Description of PICOTS was nicely done and a new term
for me, one who spends the day seeing patients.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/prevhosp/imp-handouts.pdf
June 02, 2025 - We include a description of the problem, current diagnoses, any recent lab or x ray results, and
the … Reports Can Be Used
(for use with Implementation Scripted Exercise)
Nursing Home
Meetings Meeting Description … Program for Nursing Homes: On-Time Preventable Hospital and ED Visits 2
Nursing Home
Meetings Meeting Description … Program for Nursing Homes: On-Time Preventable Hospital and ED Visits 3
Nursing Home
Meetings Meeting Description
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-201-fullreport.pdf
March 01, 2019 - Measure Description
Please provide a non-technical description of the measure that conveys what it measures … Research Evidence
Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study
sample
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-247-fullreport.pdf
December 01, 2019 - Measure Description
Please provide a non-technical description of the measure that conveys what it measures … Research Evidence
Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study
sample
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fullreport.pdf
March 01, 2018 - Measure Description
Please provide a non-technical description of the measure that conveys what it measures … Research Evidence
Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study
sample
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
March 19, 2018 - Further description
as to the domains that led to
downgrading a given outcome are
provided in the … Further description
as to the domains that led to
downgrading a given outcome
within each
intervention … Further description
as to the domains that led to
downgrading a given outcome
within each
intervention … Public reviewer
#1, Anonymous
KQ1c A description of how dosing (frequency
and cumulative dose) differs
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-fullreport.pdf
February 01, 2018 - Measure Description
Please provide a non-technical description of the measure that conveys what it measures … Research Evidence
Research evidence should include a brief description of the evidence base for valid … Include results of all tests of validity and reliability, including description(s) of the study
sample
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-rapid-review.pdf
April 01, 2024 - Bias
Study Design
(n Analyzed)
Patient
Population
Setting/Care
Transition
Condition
Description … Bias
Study Design
(n Analyzed)
Patient
Population
Setting/Care
Transition
Condition
Description … Bias
Study Design
(n Analyzed)
Patient
Population
Setting/Care
Transition
Condition
Description … Bias
Study Design
(n Analyzed)
Patient
Population
Setting/Care
Transition
Condition
Description … Bias
Study Design
(n Analyzed)
Patient
Population
Setting/Care
Transition
Condition
Description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_disposition-comments.pdf
July 14, 2016 - discussion of the study by Putkonen and colleagues
(2013), the text describes on p. 66 gives an excellent
description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/schizophrenia-adult_research-protocol.pdf
September 23, 2016 - Definition and description of schizophrenia in the DSM-5.
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/item-sets/elicitation/about-patient-narratives-elicitation-protocol-cg30-2315.pdf
April 24, 2018 - CropGrayImages false
/CropMonoImages false
/DSCReportingLevel 0
/DefaultRenderingIntent /Default
/Description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule-future_research.pdf
May 01, 2013 - Orienting Stakeholders
The stakeholders were provided by email a description of the project, the draft … this report.
6
Orienting Stakeholders
By emailed letters we provided the stakeholders with a description … and assessed one to three study design
suggestions for each of the final FRN, with limited textual description … List of Ongoing Studies
Title/ Identifier(s) Study Dates Description Sponsor or Principal
Investigator … Accessed at:
clinicaltrials.gov/ct2/show/NC
T01469819
B-2
Title/ Identifier(s) Study Dates Description
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/assessing-the-risk-of-bias-in-systematic-reviews-of-health-care-interventions-01.pdf
May 01, 2005 - Description of risk-of-bias categories and study design-specific assessment criteria
for randomized … The Cochrane
Handbook of Systematic Reviews offers a more detailed description of intention to treat … Description of risk-of-bias categories and study design-specific assessment criteria for randomized and … Categories of Bias
Related to Design and
Conduct of the Studyb Description … A
misleading subgroup analysis may not fit the classic description of bias or confounding, but can
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary20/suicide-risk-in-adolescents-adults-and-older-adults-screening
April 15, 2013 - * Weights are from random-effects analysis
Text Description . … * Weights are from random-effects analysis
Text Description . … * Weights are from random-effects analysis
Text Description . … Text Description . … Text Description .
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary25/screening-for-abnormal-blood-glucose-and-type-2-diabetes-october-2015
April 13, 2015 - Text Description. … Text Description. … * Included in the 2008 report. 22
Text Description. … * Included in the 2008 report. 22
Text Description. … * Included in the 2008 report. 22
Text Description.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/assessing-the-risk-of-bias-in-systematic-reviews-of-health-care-interventions-01_0.pdf
May 01, 2005 - Description of risk-of-bias categories and study design-specific assessment criteria
for randomized … The Cochrane
Handbook of Systematic Reviews offers a more detailed description of intention to treat … Description of risk-of-bias categories and study design-specific assessment criteria for randomized and … Categories of Bias
Related to Design and
Conduct of the Studyb Description … A
misleading subgroup analysis may not fit the classic description of bias or confounding, but can
-
www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/pcpf-module-4-practice-management.pdf
September 01, 2015 - Clinical staff and descriptions
Discipline/
Degree Description
Medical doctor
(M.D.) and doctor … Primary Care Practice Facilitation Curriculum MODULE 4 M4-11
Discipline/
Degree Description
Registered … Table 4.3 provides a list and
description of commonly used coding systems.
Table 4.3.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nppv-respiratory-failure_research-protocol.pdf
April 21, 2011 - Amendments
In the event of protocol amendments, the date of each amendment will be accompanied by a
description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_research-protocol.pdf
January 13, 2014 - Amendments
In the event of protocol amendments, the date of each amendment will be
accompanied by a description
-
www.ahrq.gov/pqmp/implementation-qi/toolkit/asthma/qi-strategies.html
July 01, 2021 - For a more detailed description of the approach that was adapted, refer to the article entitled “ A